Reborn Lifestyle Adjustment Program
1 other identifier
observational
60
1 country
1
Brief Summary
The aim of this study is to investigate the effects of the reborn lifestyle regulation program on physical activity, fatigue level, pain, mental health burden and quality of life in breast cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
September 19, 2024
CompletedFirst Posted
Study publicly available on registry
September 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedSeptember 23, 2024
August 1, 2024
6 months
September 19, 2024
September 19, 2024
Conditions
Outcome Measures
Primary Outcomes (7)
Breast Cancer Specific Quality of Life Scale
An adjunct to the EORTC QLQ-C30, this scale assesses breast cancer-specific symptoms and treatment-related side effects. It includes subscales for body image, sexual function, and treatment side effects, rated on a 4-point Likert scale. The Turkish version was adapted by Demirci et al. in 2011.
12 weeks
Modified Borg Scale
Developed by Borg in 1970, this unidirectional scale (0-10) measures the effort exerted during physical exercise, particularly in assessing dyspnea severity. Participants rate their dyspnea over the past week, with "0" indicating no shortness of breath and "10" indicating severe shortness of breath.
12 weeks
Sit up Test
This test measures leg strength and endurance by counting how many times a participant can sit and stand from a chair within 30 seconds. A score of fewer than 10 sit-ups indicates lower extremity weakness. The Turkish validity and reliability were established by Demir and Öztürk in 2020.
12 weeks
Cancer Fatigue Scale
The CFS, developed by Okuyama et al. (2000) and validated in Turkish by Şahin et al. (2018), evaluates fatigue in individuals with cancer across three domains: physical, emotional, and cognitive. The scale consists of 15 items, rated on a Likert scale from 1 (not at all) to 5 (very much).
12 weeks
McGill-Melzack Pain Questionnaire
Developed by Melzack in the 1970s and validated in Turkish by Kuguoglu et al. (2003), the MPQ assesses the quality and intensity of pain through four sections, including sensory and perceptual dimensions. Scores range from 0 to 112, with higher scores indicating more severe pain.
12 weeks
Depression Anxiety Stress Scale (DASS-21)
The DASS-21, developed by Lovibond \& Lovibond (1995) and validated in Turkish by Sarıçam (2018), assesses mental health across three dimensions: depression, anxiety, and stress. Each dimension consists of 7 items rated on a 4-point Likert scale. Higher scores indicate more severe symptoms.
12 weeks
Pittsburgh Sleep Quality Index (PSQI)
Developed by Buyyse et al. (1989) and validated in Turkish by Agargun et al., the PSQI assesses sleep quality over the past month across seven components. Scores range from 0 to 21, with higher scores indicating poorer sleep quality.
12 weeks
Secondary Outcomes (4)
European Organization for Research and Treatment of Cancer Quality of Life Scale
12 weeks
University of Rhode Island Scale for Assessing Change
Baseline
Mini Mental Status Examination Test
Baseline
Visual Analog Scale
12 weeks
Study Arms (2)
Intervention Group
This intervention group consists of multi-component modules developed to help individuals with breast cancer adopt a healthy lifestyle and improve their quality of life. The sessions are based on the 'Do Live Well' model, Kolb's Experiential Learning Theory, and CBT-based problem-solving skills.
Control Group
Patients in the control group will continue conventional medical treatments, occupational therapy and physiotherapy sessions.
Interventions
The sessions are based on the 'Do Live Well' model, Kolb's Experiential Learning Theory, and CBT-based problem-solving skills. Introduction to the Reborn Lifestyle: Core principles of the Reborn Program for building a healthy lifestyle during and after breast cancer. Physical Activity: The role of physical activity during treatment and exercises to boost energy levels. Fatigue Management: Scientific methods for managing fatigue during and after treatment. Pain Management: Effective techniques to reduce pain and improve quality of life. Mental Health Burden: Strategies to alleviate mental health burdens and cope with stress. Quality Sleep: Practical methods to improve sleep patterns and achieve quality rest. Preventive Rehabilitation Approaches: Essential rehabilitation strategies to protect health and reduce recurrence risk. The study will be conducted online, with evaluations and sessions via Zoom before and after the 12-week modules.
Patients in the control group will continue conventional medical treatments, occupational therapy and physiotherapy sessions.
Eligibility Criteria
Female patients with breast cancer
You may qualify if:
- Being a female individual aged 18 or older
- Have been diagnosed with Stage I, II, or III breast cancer
- At least 6 months have passed since the completion of chemotherapy
- Approval by an oncologist to participate in the study
- Having internet access and the ability to connect online
- Scoring above 23 on a standardized Mini Mental Status Examination Test
- Being in the contemplation stage according to the Transtheoretical Model
You may not qualify if:
- Having a neurological or systemic disease that could significantly affect the course of the intervention
- Having metastasis that could impact the sustainability of the study
- Suffering from neuropathic pain
- Having participated in a healthy lifestyle program within the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Atlas Universitylead
Study Sites (1)
Istanbul Atlas University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sena Ondes, MSc
Atlas University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2024
First Posted
September 23, 2024
Study Start
August 1, 2024
Primary Completion
February 1, 2025
Study Completion
August 1, 2025
Last Updated
September 23, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share